BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia
Authors
Keywords
<em class="EmphasisTypeItalic ">BCL2</em>, Expression, HSCT, ABT-199/venetoclax, AML
Journal
Diagnostic Pathology
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-29
DOI
10.1186/s13000-019-0841-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Targeted Agents in Acute Myeloid Leukemia: New Hope on the Rise
- (2019) Stephan R. Bohl et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia
- (2018) Laixi Bi et al. BMC CANCER
- Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia
- (2018) Ze Hong et al. Cancer Biomarkers
- Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia
- (2018) Raj Bhayadia et al. JOURNAL OF CLINICAL ONCOLOGY
- Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression
- (2018) J. Lin et al. ONCOGENE
- H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia
- (2018) Ting-juan Zhang et al. Clinical Epigenetics
- Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies
- (2018) Jing-dong Zhou et al. Clinical Epigenetics
- Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies
- (2017) Jing-dong Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- High receptor tyrosine kinase (FLT3, KIT) transcript versus anti-apoptotic (BCL2) transcript ratio independently predicts inferior outcome in pediatric acute myeloid leukemia
- (2015) Surender Kumar Sharawat et al. BLOOD CELLS MOLECULES AND DISEASES
- ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
- (2015) Shundong Cang et al. Journal of Hematology & Oncology
- Molecular therapy for acute myeloid leukaemia
- (2015) Catherine C. Coombs et al. Nature Reviews Clinical Oncology
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hox gene dysregulation in acute myeloid leukemia
- (2014) Etienne De Braekeleer et al. Future Oncology
- Targeting BCL2 for the Treatment of Lymphoid Malignancies
- (2014) Mary Ann Anderson et al. SEMINARS IN HEMATOLOGY
- ABT-199: Taking Dead Aim at BCL-2
- (2013) Matthew S. Davids et al. CANCER CELL
- Reprogramming cell death: BCL2 family inhibition in hematological malignancies
- (2013) Lydia Scarfò et al. IMMUNOLOGY LETTERS
- MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia
- (2013) M Díaz-Beyá et al. LEUKEMIA
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
- (2013) R. Pan et al. Cancer Discovery
- Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
- (2012) Matthew S. Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of HOX genes in normal hematopoiesis and acute leukemia
- (2012) R A Alharbi et al. LEUKEMIA
- Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
- (2011) Andrew W. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia
- (2010) Ebru Coskun et al. LEUKEMIA RESEARCH
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
- (2009) M. H. Kang et al. CLINICAL CANCER RESEARCH
- Cell Death
- (2009) Richard S. Hotchkiss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bcl-2 inhibitors: small molecules with a big impact on cancer therapy
- (2008) M Vogler et al. CELL DEATH AND DIFFERENTIATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More